Niemann-Pick Type C Disease Often Overlooked
Are you interested in learning more about Niemann-Pick type C disease?
Prof. Peter Bauer, CSO of CENTOGENE, introduces you to NP-C and discusses the importance of a robust biomarker for the diagnosis and monitoring of this disease.
Discover how our screening programs for NP-C can enable diagnosis, prediction and therapy monitoring for your patients.
Webinar Content:
- CENTOGENE’s integrated diagnostic concept for rare diseases
- The challenge with rare variant classification and medical interpretation
- The value of biomarkers in rare diseases – biomarkers in Niemann-Pick type C disease
Our Speaker
![CENTOGENE Webinar Speaker Peter Bauer](/fileadmin/_processed_/a/e/csm_centogene-executive-board-Peter-Bauer_210x210px_d3c9160c58.jpg)
Prof. Peter Bauer, M.D.
Chief Medical and Genomic Officer, CENTOGENE
Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Medical and Genomic Officer, where […]